Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Shares Outstanding (Weighted Average): 2019-2024

Historic Shares Outstanding (Weighted Average) for Biodesix (BDSX) over the last 6 years, with Dec 2024 value amounting to $7.3 million.

  • Biodesix's Shares Outstanding (Weighted Average) rose 1.00% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 1.00%. This contributed to the annual value of $7.3 million for FY2024, which is 60.78% up from last year.
  • Per Biodesix's latest filing, its Shares Outstanding (Weighted Average) stood at $7.3 million for FY2024, which was up 60.78% from $4.5 million recorded in FY2023.
  • In the past 5 years, Biodesix's Shares Outstanding (Weighted Average) ranged from a high of $7.3 million in FY2024 and a low of $1.3 million during FY2020.
  • For the 3-year period, Biodesix's Shares Outstanding (Weighted Average) averaged around $4.6 million, with its median value being $4.5 million (2023).
  • Data for Biodesix's Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 114.94% (in 2023) over the last 5 years.
  • Biodesix's Shares Outstanding (Weighted Average) (Yearly) stood at $1.3 million in 2020, then climbed by 17.96% to $1.6 million in 2021, then spiked by 34.45% to $2.1 million in 2022, then soared by 114.94% to $4.5 million in 2023, then skyrocketed by 60.78% to $7.3 million in 2024.